Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. It offers products such as pathflow, promate, genesig, snpsig, mygo, versalab, co-prep, respiratory, gastrointestinal and transplant products. The company's products include covid-19 rapid antigen self-test, co-prep automated liquid handling system and others. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt develops the proprietary technology platform NOVAPREP, a next-generation liquid-based cytology solution focused on cancer management. The company’s cytology solution is also used in medical laboratories for diagnoses of diseases based on the study of organs and tissues on a molecular level. It has operations in France and the UK. Novacyt is headquartered in Velizy Villacoublay, Ile-de-France, France.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Novacyt SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Novacyt SA Company Overview
- Novacyt SA Company Snapshot
- Novacyt SA Pipeline Products and Ongoing Clinical Trials Overview
- Novacyt SA - Pipeline Analysis Overview
- Novacyt SA - Key Facts
- Novacyt SA - Major Products and Services
- Novacyt SA Pipeline Products by Development Stage
- Novacyt SA Pipeline Products Overview
- Diagnostic Assay - Aspergillus
- Diagnostic Assay - Aspergillus Product Overview
- Diagnostic Assay - Pneumocystis
- Diagnostic Assay - Pneumocystis Product Overview
- Direct-To-PCR Extraction Device
- Direct-To-PCR Extraction Device Product Overview
- Genesig - Cytomegalovirus Test
- Genesig - Cytomegalovirus Test Product Overview
- Genesig Kit - Human Papillomavirus 14
- Genesig Kit - Human Papillomavirus 14 Product Overview
- Genesig q24
- Genesig q24 Product Overview
- LAMP COVID-19 Test
- LAMP COVID-19 Test Product Overview
- Multiplex Test - Mosquito-Borne Diseases
- Multiplex Test - Mosquito-Borne Diseases Product Overview
- Next Generation Lateral Flow Test - COVID -19
- Next Generation Lateral Flow Test - COVID -19 Product Overview
- Onconostica
- Onconostica Product Overview
- PathFlow COVID-19 Rapid Antigen Pro
- PathFlow COVID-19 Rapid Antigen Pro Product Overview
- PathFlow COVID-19 Rapid Antigen Self-Test
- PathFlow COVID-19 Rapid Antigen Self-Test Product Overview
- PathFlow SARS-CoV-2 Antigen Self-Test
- PathFlow SARS-CoV-2 Antigen Self-Test Product Overview
- PathFlow SARS-CoV-2 SMART IgG Test
- PathFlow SARS-CoV-2 SMART IgG Test Product Overview
- PROmate SARS-CoV-2 E484K Test
- PROmate SARS-CoV-2 E484K Test Product Overview
- Single Nucleotide Polymorphism Assay
- Single Nucleotide Polymorphism Assay Product Overview
- Two-Gene Target PROmate Test
- Two-Gene Target PROmate Test Product Overview
- Novacyt SA - Key Competitors
- Novacyt SA - Key Employees
- Novacyt SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Novacyt SA, Recent Developments
- Jan 30, 2023: Novacyt : DHSC Claim update - Trial date listed
- Jan 26, 2023: Novacyt : Full Year 2022 trading update
- Dec 07, 2022: Novacyt : Non-Executive Director Change
- Nov 10, 2022: Novacyt Announces David Allmond is stepping down as Chief Executive Officer
- Sep 29, 2022: Novacyt announces Half year 2022 results
- Sep 29, 2022: Novacyt Half Year 2022 Results
- Jul 28, 2022: Launch of research-use-only adenovirus F41 assay
- Jul 28, 2022: Novacyt SA: Launch of Research-Use-Only Adenovirus F41 Assay
- Jun 28, 2022: Novacyt : Launch of monkeypox assay
- Apr 28, 2022: Novacyt Full year 2021 results and update on growth strategy
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Novacyt SA Pipeline Products and Ongoing Clinical Trials Overview
- Novacyt SA Pipeline Products by Equipment Type
- Novacyt SA Pipeline Products by Indication
- Novacyt SA, Key Facts
- Novacyt SA, Major Products and Services
- Novacyt SA Number of Pipeline Products by Development Stage
- Novacyt SA Pipeline Products Summary by Development Stage
- Diagnostic Assay - Aspergillus - Product Status
- Diagnostic Assay - Aspergillus - Product Description
- Diagnostic Assay - Pneumocystis - Product Status
- Diagnostic Assay - Pneumocystis - Product Description
- Direct-To-PCR Extraction Device - Product Status
- Direct-To-PCR Extraction Device - Product Description
- Genesig - Cytomegalovirus Test - Product Status
- Genesig - Cytomegalovirus Test - Product Description
- Genesig Kit - Human Papillomavirus 14 - Product Status
- Genesig Kit - Human Papillomavirus 14 - Product Description
- Genesig q24 - Product Status
- Genesig q24 - Product Description
- LAMP COVID-19 Test - Product Status
- LAMP COVID-19 Test - Product Description
- Multiplex Test - Mosquito-Borne Diseases - Product Status
- Multiplex Test - Mosquito-Borne Diseases - Product Description
- Next Generation Lateral Flow Test - COVID -19 - Product Status
- Next Generation Lateral Flow Test - COVID -19 - Product Description
- Onconostica - Product Status
- Onconostica - Product Description
- PathFlow COVID-19 Rapid Antigen Pro - Product Status
- PathFlow COVID-19 Rapid Antigen Pro - Product Description
- PathFlow COVID-19 Rapid Antigen Self-Test - Product Status
- PathFlow COVID-19 Rapid Antigen Self-Test - Product Description
- PathFlow SARS-CoV-2 Antigen Self-Test - Product Status
- PathFlow SARS-CoV-2 Antigen Self-Test - Product Description
- PathFlow SARS-CoV-2 SMART IgG Test - Product Status
- PathFlow SARS-CoV-2 SMART IgG Test - Product Description
- PROmate SARS-CoV-2 E484K Test - Product Status
- PROmate SARS-CoV-2 E484K Test - Product Description
- Single Nucleotide Polymorphism Assay - Product Status
- Single Nucleotide Polymorphism Assay - Product Description
- Two-Gene Target PROmate Test - Product Status
- Two-Gene Target PROmate Test - Product Description
- Novacyt SA, Key Employees
- Novacyt SA, Other Locations
- Novacyt SA, Subsidiaries
- Glossary
- Novacyt SA Pipeline Products by Equipment Type
- Novacyt SA Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Biosynex SA
- Zimmer Biomet Robotics
- Mauna Kea Technologies SAS
- AgCom biotech S.A.R.L.
- Anagenesis Biotechnologies SAS
- Eurobio Scientific SA
- Stilla Technologies SAS
